Form 4 · Filed Jun 24, 2026, 08:55 PM UTC
VERA/Vera Therapeutics, Inc.
Fordyce Marshall — PRESIDENT AND CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | S | sell | 18,412 | $38 | $698,387 | 198,332 |
| Jun 23, 2026 | S | sell | 88 | $38 | $3,382 | 198,244 |
Source: SEC EDGAR raw filing ↗ · Accession 0001859453-26-000008